Both in Diagnostics
Immucell vs Achieve Life Sciences
Over the past year ICCC returned +68.5% and ACHV returned +30.3%; their daily moves had a correlation of -0.02.
ICCC +68.5% ACHV +30.3%Growth of $1, one year, split-adjusted
| Metric | ICCC | ACHV |
|---|---|---|
| Price | $10.26 | $6.83 |
| Market cap | $93.2M | $704.2M |
| Today | −0.58% | −5.01% |
| 1 month | +6.9% | −9.3% |
| 6 months | +17.5% | +55.9% |
| Year to date | +66.8% | +37.4% |
| 1 year | +70.1% | +38.0% |
| Revenue growth (YoY) | +11.5% | — |
| Gross margin | 33.9% | — |
| Net margin | 25.5% | — |
| P/E (TTM) | 118.3× | — |
| Price / sales | 3.0× | — |
| Net cash | $557.3K | $172.4M |
| Dividend yield | — | — |
| Volatility (60d) | 37.4% | 59.7% |
| Short % of float | 0.3% | 28.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).